Dr Reddy's Laboratories Company Profile (NASDAQ:DRREDDY)

About Dr Reddy's Laboratories (NASDAQ:DRREDDY)

Dr Reddy

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DRREDDY
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
 

Frequently Asked Questions for Dr Reddy's Laboratories (NASDAQ:DRREDDY)

What is Dr Reddy's Laboratories' stock symbol?

Dr Reddy's Laboratories trades on the NASDAQ under the ticker symbol "DRREDDY."

Who are some of Dr Reddy's Laboratories' key competitors?

How do I buy Dr Reddy's Laboratories stock?

Shares of Dr Reddy's Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.


MarketBeat Community Rating for Dr Reddy's Laboratories (NASDAQ DRREDDY)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  19 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about Dr Reddy's Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Dr Reddy's Laboratories (NASDAQ:DRREDDY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
Earnings by Quarter for Dr Reddy`s Laboratories (NASDAQ:DRREDDY)
Earnings History by Quarter for Dr Reddy's Laboratories (NASDAQ DRREDDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/30/2014Q1 15$0.54ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr Reddy's Laboratories (NASDAQ:DRREDDY)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
Latest Headlines for Dr Reddy's Laboratories (NASDAQ:DRREDDY)
Source:
DateHeadline
thestreet.com logoAurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr.
www.thestreet.com - September 12 at 6:45 PM
finance.yahoo.com logoDr. Reddy's Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference
finance.yahoo.com - September 12 at 6:45 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – RDY
finance.yahoo.com - September 8 at 11:29 PM
businesswire.com logoDr. Reddy's Laboratories Announces the Launch of Metaxalone Tablets, USP in the U.S. Market
www.businesswire.com - September 6 at 5:37 AM
reuters.com logoBRIEF-Dr.Reddy's Labs says ruling in favour of co on generic version of Suboxone doesn't infringe U.S. patents as asserted by Indivior
www.reuters.com - September 1 at 6:18 PM
bloomberg.com logoDuds of Booming Indian Stock Market Win Over $20 Billion Manager
www.bloomberg.com - August 28 at 10:50 PM
nasdaq.com logoDr. Reddy’s Laboratories Breathes New Life into Doan’s® in New Marketing Campaign
www.nasdaq.com - August 28 at 10:50 PM
nasdaq.com logoDr. Reddy's Labs Announces Out-Licensing Of DFD-06 To Encore Dermatology
www.nasdaq.com - August 22 at 3:44 AM
businesswire.com logoDr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
www.businesswire.com - August 22 at 3:44 AM
thestreet.com logoDr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined In Value?
www.thestreet.com - August 12 at 5:22 PM
businesswire.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors
www.businesswire.com - August 11 at 11:29 PM
bloomberg.com logoFather and Son Duo Turn Family Drug Firm Into World Beater
www.bloomberg.com - August 9 at 11:15 PM
marketwatch.com logoTeva shares plummet 24% on cheaper generic drug prices, pulling rivals lower
www.marketwatch.com - August 3 at 5:06 PM
zacks.com logoDr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise
www.zacks.com - July 31 at 5:48 PM
nasdaq.com logoDr. Reddy's Laboratories Becomes Oversold
www.nasdaq.com - July 28 at 8:01 PM
reuters.com logoUPDATE 1-India's Dr Reddy's Q1 profit slumps on pricing pressures in U.S.
www.reuters.com - July 27 at 6:26 PM
businesswire.com logoDr. Reddy’s Q1 FY18 Financial Results
www.businesswire.com - July 27 at 6:25 PM
rttnews.com logoDr Reddy's Laboratories Ltd. Bottom Line Falls 55% In Q1
www.rttnews.com - July 27 at 6:25 PM

Social

Chart

Dr Reddy's Laboratories (DRREDDY) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff